Cargando…
Lung Cancer Organoids: The Rough Path to Personalized Medicine
SIMPLE SUMMARY: Lung cancer is very difficult to cure, especially when it has spread to other parts of the body. One of the main reasons that delay the identification of effective therapies is the complexity of lung cancer cells, which can be very different among individual patients. Organoids are s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367558/ https://www.ncbi.nlm.nih.gov/pubmed/35954367 http://dx.doi.org/10.3390/cancers14153703 |